We noticed ERBB2 (HER2) among the plasma membrane proteins with increased expression in G0 and decided to further study this protein because of its known importance in other malignancies, especially breast cancer [17], [18], [19], [20] and because of the many drugs available that target it [18,21]. The gene discussed is ERBB2; the disease is breast carcinoma.